Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma.

MLA

Loibl, Sibylle, et al. “Response and Prognosis after Neoadjuvant Chemotherapy in 1,051 Patients with Infiltrating Lobular Breast Carcinoma.” Breast Cancer Research and Treatment, vol. 144, no. 1, Feb. 2014, pp. 153–62. EBSCOhost, https://doi.org/10.1007/s10549-014-2861-6.

APA

Loibl, S., Volz, C., Mau, C., Blohmer, J.-U., Costa, S. D., Eidtmann, H., Fasching, P. A., Gerber, B., Hanusch, C., Jackisch, C., Kümmel, S., Huober, J., Denkert, C., Hilfrich, J., Konecny, G. E., Fett, W., Stickeler, E., Harbeck, N., Mehta, K. M., … Untch, M. (2014). Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma. Breast Cancer Research and Treatment, 144(1), 153–162. https://doi.org/10.1007/s10549-014-2861-6

Chicago

Loibl, Sibylle, Cristina Volz, Christine Mau, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, et al. 2014. “Response and Prognosis after Neoadjuvant Chemotherapy in 1,051 Patients with Infiltrating Lobular Breast Carcinoma.” Breast Cancer Research and Treatment 144 (1): 153–62. doi:10.1007/s10549-014-2861-6.